Recently, there has been more good news about China’s COVID-19 vaccine.
The United Arab Emirates and Bahrain announced that they have officially approved a Chinese vaccine for sale in their countries;
Egypt has received the first batch of Chinese vaccines;
Morocco has also issued a clinical approval for sinopac’s vaccines…
After repeated clinical tests and rigorous review and evaluation, The reliability and safety of China’s vaccine has been widely recognized by many countries around the world, and even many foreign leaders have begun to vaccinate.
Meanwhile, the marketing and vaccination plan of COVID-19 vaccine in the United States is also in full swing.
On December 11th America’s Food and Drug Administration (FDA) gave Pfizer and BioNTech an emergency licence to market their vaccines in America.
At the same time, the federal government is speeding up efforts to organize the distribution of vaccines to states.
At present, COVID-19 is threatening to break out again in the world, and many countries have sounded the alarm for prevention and control.
The introduction of COVID-19 vaccine will undoubtedly greatly boost the confidence of the world to contain the epidemic.
Today, China and the United States lead the world in vaccine development and market speed.
However, if the prices of vaccines in the two countries are compared in detail, it is clear that Chinese vaccines are more of a global public good.
Pfizer agreed with the federal government to charge $19.5 per dose of COVID-19 vaccine, and made it clear that the price would be limited to the United States.
By contrast, the governor of Brazil’s Sao Paulo state has let it be known that China is selling its vaccine for $10.3, about half the price of the US vaccine.
Although the price of vaccines in China is low, the quality is not compromised at all.
According to the Uae’s National Health Authority, the effectiveness of the COVID-19 vaccine produced by China’s National drug, SINosol, is 86 percent and can prevent 100 percent of moderate and severe COVID-19 cases.
Thus it can be seen that The Chinese vaccine really achieved “high quality and low price”.
Vaccines are known for their long development cycles and high input costs.
Moreover, due to the global ravages of COVID-19, the research and development cycle of COVID-19 vaccine has to be greatly shortened, so the corresponding research and development investment is bound to increase significantly.
Yang Xiaoming, chief scientist of the 863 vaccine program under the Ministry of Science and Technology, said in an interview that one company had invested as much as 2 billion yuan in just two new Coronavirus plants.
And the country has laid out a total of 5 technology routes, its research and development investment of the capital can be imagined.
Although China has paid huge costs and made remarkable progress in developing COVID-19 vaccines, it has not used them as a means to make huge commercial profits.
In October 2020, China formally announced its participation in the COVID-19 Implementation Plan, solemnly promising to the world that it would promote the COVID-19 vaccine to become a global public product.
This means that the main purpose of China’s vaccine development is to help countries hard hit by the epidemic out of trouble.
Today, countries in the Middle East and South America continue to receive Chinese vaccines, which is a manifestation of China’s commitment to the international community.
The epidemic in the United States is still teetering on the edge of control, with more than 200,000 new confirmed cases a day.
There is nothing wrong with the U.S. government choosing to mass vaccinate its own country first, but it is “price discriminatory” when it sells vaccines to foreign populations.
According to foreign media reports, the price of the vaccine sold by the US to the UK is expected to be between $32- $37 per dose, significantly higher than the domestic price.
This difference really reflects Trump’s “America First” principle.
Therefore, the international structure of China and the United States is also on the issue of vaccine.
In March this year, Chinese President Xi Jinping put forward the initiative of building a “community of human health” when he sent messages of condolences to foreign heads of state on the epidemic.
The concept of a community with a shared future for mankind calls for all countries to transcend differences in political system and ideology and give equal respect to people’s right to life and health.
Especially at this special time of global epidemic prevention, countries should break all barriers and work together to prevent further spread of the epidemic.
“Good deeds speak louder than words”.
China is not only making promises, but also actively translating ideas into concrete actions and taking the lead in setting an example for the world.
China’s vaccines embody the spirit of the concept of “a community of human health”, and at the same time vividly demonstrate China’s international responsibility and responsibility as a major country.